Form 4: AbbVie Executive Azita Saleki-Gerhardt Reports Stock Sale
SEC Form 4 Filing
EVP and Chief Operations Officer of AbbVie, Azita Saleki-Gerhardt, reports the sale of 17,056 shares of common stock on February 28, 2025.
Summary
- Azita Saleki-Gerhardt, EVP and Chief Operations Officer of AbbVie, filed a Form 4 with the SEC.
- The report details a transaction on February 28, 2025, where 17,056 shares of AbbVie common stock were disposed of at a price of $205.02 per share.
- Following the transaction, Saleki-Gerhardt directly owns 177,292 shares of AbbVie common stock.
- She also has indirect ownership of 2,601 shares through a profit-sharing trust and 3,873 shares held by her spouse, but she disclaims beneficial ownership of the spouse's shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard SEC filing reporting a stock sale. The sale itself doesn't necessarily indicate a positive or negative outlook.
Industry Context
This filing is a routine disclosure of insider trading activity. It provides transparency into the actions of company executives regarding their holdings of company stock. It is difficult to assess the impact of this single transaction without knowing the broader context of insider trading activity at AbbVie and the executive's overall investment strategy.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transaction: Sale of 17,056 shares of AbbVie common stock. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.